In the context of NSCLC and LUAD, researchers Liu et al. [215] explored the resistance to the common treatment of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) and their implications with PD-L1 and YY1. The gene discussed is CD274; the disease is non-small cell lung carcinoma.